U.S. Markets closed

Global Implantable Cardioverter Defibrillators Market to 2023

DUBLIN, Sept. 30, 2019 /PRNewswire/ -- The "Interventional Cardiology: Implantable Cardioverter Defibrillators" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The combined global market for ICD devices totals nearly $8bn, and is expected to climb at a CAGR of 4.4% through 2023.

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the implantable cardioverter defibrillator (ICD) products market. Types of cardiac defibrillators covered by the scope of this report include ICDs, subcutaneous ICDs (S-ICDs), and cardiac resynchronization therapy-defibrillators (CRT-Ds).

The most influential driver of the global ICDs market is the increasing prevalence of cardiovascular disease (CVD) as a result of the expanding geriatric population and an increasing prevalence of CVD risk factors such as obesity and diabetes.

Key Topics Covered:

Executive Summary
i. Cardiac rhythm disorders overview
ii. Global implantable cardioverter defibrillator products market
Exhibit ES-1: Global implantable cardioverter defibrillator products market forecast ($m), 2018-23
Exhibit ES-2: Global implantable cardioverter defibrillator products market, by country/region, 2018
a. Market drivers and limiters
Exhibit ES-3: Drivers and limiters of growth - implantable cardioverter defibrillator products
b. Device segment insights
c. Technology trends
d. Market leaders
e. Competitive strategies
f. Emerging competition
iii. Methodology

1. Cardiac Rhythm Disorders Overview
Exhibit 1-1: Estimated prevalence rates of conduction disorders and cardiac arrhythmias, based on healthcare utilization, select countries
Exhibit 1-2: Estimated number of hospital discharges for conduction disorders and cardiac arrhythmias, select countries
1.1 Sick sinus syndrome
1.2 Bradycardia
1.3 Heart block
1.4 Tachycardia
1.5 Atrial fibrillation
Exhibit 1-3: Estimated prevalence of atrial fibrillation, select countries, 2018
1.6 Heart failure
Exhibit 1-4: Estimated prevalence of chronic heart failure, select countries, 2018
Exhibit 1-5: Estimated prevalence of acute decompensated heart failure, select countries, 2018
1.7 Diagnosis and treatment
1.8 Bibliography

2. Implantable Cardioverter Defibrillator Products
2.1 Implantable cardioverter defibrillator systems
Exhibit 2-1: Generic NBD codes for implantable cardioverter defibrillators
2.1.1 Implantable cardioverter defibrillator products
Exhibit 2-2: Selected ICDs and manufacturers
Exhibit 2-3: Selected CRT-Ds and manufacturers
2.1.2 Developments in implantable cardioverter defibrillator technology
2.2 Bibliography

3. Implantable Cardioverter Defibrillator Products Market
3.1 Global market insights
3.1.1 Market value
Exhibit 3-1: ICD products, global market forecast ($m), 2018-23
Exhibit 3-2: ICD products, global market forecast ($m), by product type, 2018-2
Exhibit 3-3: Global ICD products market, share by country/region, 2018
Exhibit 3-4: Global ICD product sales, global market forecast ($m), by country/region, 2018-23
3.1.2 Technology trends
3.1.3 Market drivers and limiters
Exhibit 3-5: Drivers and limiters of market growth - ICD products
3.1.4 ICD products overview
Exhibit 3-6: ICD products, global market forecast ($m), by product type, 2018-23
3.1.5 Market leaders
3.1.6 Competitive strategies
3.1.7 Emerging competition
3.2 Global competitors
Exhibit 3-7: Global ICD products market, share by supplier, 2018
3.3 Market forecast
3.3.1 Market forecast: US
Exhibit 3-8: US ICD implantations, procedure volumes forecast (000s), 2018-23
Exhibit 3-9: US ICD product sales, market forecast ($m), by product type, 2018-23
3.3.2 Market forecast: five major EU markets
Exhibit 3-10: 5EU ICD implantations, procedure volumes forecast (000s), 2018-23
Exhibit 3-11: 5EU ICD product sales, market forecast ($m), by product type, 2018-2
3.3.3 Market forecast: Japan
Exhibit 3-12: Japanese ICD implantations, procedure volumes forecast (000s), 2018-23
Exhibit 3-13: Japanese ICD product sales, market forecast ($m), by product type, 2018-23
3.3.4 Market forecast: rest of the world
Exhibit 3-14: RoW ICD product sales, market forecast ($m), by product type, 2018-23
3.4 Bibliography

Appendix: Company Listing

For more information about this report visit https://www.researchandmarkets.com/r/3u4bz

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision

View original content:http://www.prnewswire.com/news-releases/global-implantable-cardioverter-defibrillators-market-to-2023-300927837.html